Hillstream BioPharma, Inc.
HILS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $4 | $36 |
| - Cash | $4 | $11 | $7 | $0 |
| + Debt | $0 | $0 | $0 | $2 |
| Enterprise Value | -$3 | -$11 | -$2 | $38 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$9 | -$7 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$9 | -$8 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -9.41 | -7.14 | -0.75 | -0.3 |
| % Growth | -31.8% | -852% | -150% | – |
| Operating Cash Flow | -$11 | -$7 | -$7 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$11 | -$7 | -$7 | -$1 |